HOME >> MEDICINE >> NEWS
Excessive weight gain during pregnancy can increase breast cancer risk, study finds

(San Francisco) Gaining more than 50 pounds during pregnancy, and not losing the excess weight post-pregnancy, could triple a womans risk of developing breast cancer after menopause, according to a study conducted by researchers at Lombardi Cancer Center in Washington, DC, and in Finland. Pregnancy weight gain of 40 pounds increased breast cancer risk by 40%. The findings are to be presented April 9 at the American Association for Cancer Research (AACR) annual meeting in San Francisco.

Pregnancy weight gain has been linked in previous studies to increased estrogen levels, which in turn are believed to increase breast cancer risk, researchers said. The researchers findings are based on the study of more than 27,000 breast cancer patients in Finland, identified through a national cancer registry. Information about breast cancer diagnosis and pregnancy weight gain were obtained from a national cancer registry, maternity center registries and from a questionnaire completed by the study participants.

Significant weight gain during pregnancy may cause changes in breast tissue that increase susceptibility to breast cancer in later liferoughly equivalent to the risk of postmenopausal obesity, said Leena Hilakivi-Clarke, PhD, one of the studys investigators and associate professor of oncology at the Lombardi Cancer Center at Georgetown University Medical Center. Women who retain the added pounds after pregnancy are at the greatest risk.

Weight gain during pregnancy appeared to increase breast cancer risk only after menopause, Hilakivi-Clarke said, adding that each 1 kg (2.2 pounds) increase in pregnancy weight increased breast cancer risk by 3.9%, when adjusted for body mass index before pregnancy.

Weight gain of 25 to 35 pounds is normal in pregnancy and not associated with an increase in risk for either premenopausal or postmenopausal breast cancer, Hilakivi-Clarke noted.


'"/>

Contact: Beth Porter
bap2@georgetown.edu
202-687-4699
Georgetown University Medical Center
9-Apr-2002


Page: 1

Related medicine news :

1. Botox Treats Excessive Sweating, According To UCSF Study
2. OHSU scientists test medication to treat involuntary weight loss
3. Corrected metabolism leads to health benefits and weight loss
4. Massive weight loss conference Dallas April 1-2
5. Massive weight loss patients create mass appeal for body contouring procedures
6. Sunflower seed oil can protect low birth weight babies from infection
7. Daily supplement may boost birthweight of babies in the developing world
8. UIC offers new weight loss surgery for obese teens
9. Similar results found in both older and younger patients undergoing weight-loss surgery
10. Drugs aid weight loss among type 2 diabetes patients
11. Diffusion-weighted MRI can diagnose mad cow-related disease in humans before symptoms show

Post Your Comments:
(Date:10/22/2014)... Best Cheap Hosting USA is among the ... has recently announced that iPower ( http://www.best-cheap-hosting-usa.com/go/iPower/ ) is ... around the world. , “iPower is one of the ... providing various kinds of useful products for new and ... excellent customer service and a number of features which ...
(Date:10/22/2014)... Lintelus, Inc., an event software provider, announced ... will be speaking on the subject of “Event Technology ... 28, at the Holiday Inn in New York City. ... as a Tech Demo at 12:45pm, to educate event ... engaging event experience. , The Annual Meetings Technology Expo ...
(Date:10/22/2014)... HealthDay Reporter , TUESDAY, Oct. 21, 2014 (HealthDay ... only about half as likely as white women to become ... and the racial disparity persists even when donor eggs are ... patients became pregnant after IVF, compared to about 17 percent ... over two years to tease out the impact of race, ...
(Date:10/22/2014)... 2014 (HealthDay News) -- Measures taken by Firestone officials ... Liberia may have limited the spread of the disease ... The Firestone Natural Rubber Co. provides health services to ... nearby densely populated communities. Between Aug. 1 and ... cases among those 80,000 people. That incidence rate of ...
(Date:10/20/2014)... With a mere 19 days to ... a brief fundraising stop at the  Law Offices ... from a debate last night with his opponent Gov. ... the first seven minutes because Crist had an electric ... incident in one word: "weird." , Before touching on ...
Breaking Medicine News(10 mins):Health News:Best Cheap Hosting USA Has Recently Announced The Best Cheap Web Hosting Companies In 2014 2Health News:Jay Cormier, Sr. Vice President of Sales for Lintelus, Speaks about Event Technology Integration at Meetings Technology Expo in NYC 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 2Health News:Black Women Fare Worse With Fertility Treatments, Study Says 3Health News:Tire Company Sets Standard for Ebola Care in Liberia: CDC 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 2Health News:At Crist Fundraiser, Dan Newlin Says, "No More Robert Germans," Will Seek Changes to Florida Missing Persons Law 3
(Date:10/22/2014)... -- Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... focused on the development of oral drug delivery ... its Phase IIa clinical trial of ORMD-0801, the ... 1 diabetes. The trial was conducted in ... Food and Drug Administration (FDA) Investigational New Drug ...
(Date:10/22/2014)... --  Surefire Medical , Inc., the developer of a ... delivery of embolization agents in minimally invasive direct-to-tumor interventional ... R. Daniels , MD of the University of Southern ... Steven C. Katz , MD of the Roger Williams ... (SAB).    "The role of the SAB ...
(Date:10/22/2014)... YORK , Oct. 22, 2014 Provectus ... dermatology therapies. PV-10, its novel investigational drug for cancer, ... potential for systemic side effects. Its oncology focus is ... Provectus has completed phase 2 trials of PV-10 as ... a topical treatment for atopic dermatitis and psoriasis. ...
Breaking Medicine Technology:Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 2Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 3Oramed Pharmaceuticals Reports Positive Top-Line Data from U.S. Phase IIa Trial with Oral Insulin in Type 1 Diabetes 4Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2Provectus Biopharmaceuticals Looks at the Asian Markets: Analyst Coverage by Small Cap Traders 2
Cached News: